Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
John Minna

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

John Minna, M.D.

 Personal Overview

Biographical Sketch Details of Research Personal Overview How to Contact
John Minna
Name:
  John D. Minna, M.D.
Endowed Title:
  Max L. Thomas Distinguished Chair in Molecular Pulmonary Oncology
Sarah M. And Charles E. Seay Distinguished Chair in Cancer Research
Academic Title:
  Professor
Primary Appointment:
  Internal Medicine
Secondary Appointment:
  Pharmacology
School:
  Graduate School of Biomedical Sciences
Southwestern Medical School
Degree Program:
  Cell Regulation
Non-degree Program:
  SURF
Doris Duke
Affiliations:
  Hamon Center for Therapeutic Oncology
The Harold C. Simmons Comprehensive Cancer Center
Department Website:
  Hamon Center for Therapeutic Oncology Research
Email:
  John Minna, M.D.

 PERSONAL OVERVIEW
     
Stanford University, Stanford, CA A.B. 1963 Psychology
Stanford Medical School, Stanford, CA M.D. 1967 Medicine
Massachusetts General Hospital, Boston, MA 1967-1969 Internal Medicine
National Institutes of Health, Bethesda, MD 1969-1973 Genetics
A. Positions and Honors.
1963-1967 Predoctoral Trainee PHS, Dept of Genetics, Stanford Medical School (Dr. L. Herzenberg)
1967-1969 Internship and Residency, Dept of Medicine, Massachusetts General Hosp, Boston, MA
1969-1973 Res Assoc, Lab. of Biochemical Genetics (LBG), NHLBI, NIH (Dr. Marshall Nirenberg)
1973-1975 Head, Section on Somatic Cell Genetics, LBG, NHLBI, NIH
1974-1991 Attending Physician, Clinical Center, NIH
1975-1981 Chief, NCI-VA Medical Oncology Branch, Clinical Oncology Program, DCT, NCI, NIH
1981-1991 Chief, NCI-Navy Medical Oncology Branch, COP, DCT, NCI, NIH
1981-1991 Prof of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD
1969-1991 United States Public Health Service (PHS); Captain (06); Retired 1991
1991-Pres. Prof of Medicine & Pharmacology, UT Southwestern Medical Center Dallas (UTSWMC)
1991-1995 Director, Harold C. Simmons Cancer Center, UTSWMC, Lisa K. Simmon Distinguished Chair in Comprehensive Oncology, Chief, Division of Medical Oncology/Hematology
1995-Pres. Director, Hamon Center for Therapeutic Oncology Research and W.A. "Tex" & Deborah Moncrief Jr.
Center for Cancer Genetics, UTSWMC, Sarah M. & Charles E. Seay Distinguished Chair in Cancer
Research, Max L. Thomas Distinguished Chair in Molecular Pulmonary Oncology
Honors
PHS: Commendation Medal (1979), Meritorious Service Medical (1986), Unit Commendation Medal (1991); Rosenthal Prize for Cancer Research (1984); Milken Foundation Award for Scientific Excellence in Clinical Research (1989); Chester Stock Award, Memorial Sloan-Kettering Cancer Center (1992); Bristol Myers Squibb Award for Lung Cancer Research (1997); Moran Award Univ. Michigan (2000), NCI SPORE Program Award for Leadership (2003), Ochsner Award Smoking Related Research (2004), ASCO Scientific Achievement Award (2005), ASCO Lifetime Achievement Award (2007)
B. Selected peer-reviewed publications (2006-2007).
Sato, M., Vaughan, M. B., Girard, L., Peyton, M., Lee, W., Shames, D. S., Ramirez, R. D., Sunaga, N., Gazdar, A. F., Shay, J. W., and Minna, J. D. Multiple Oncogenic Changes (K-RASV12, p53 Knockdown, Mutant EGFRs, p16 Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells. Cancer Res, 66: 2116-2128, 2006.
Zhou, B. B., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y., Baribaud, F., Mikami, I., Reguart, N., Yang, G., Li, Y., Yao, W., Vaddi, K., Gazdar, A. F., Friedman, S. M., Jablons, D. M., Newton, R. C., Fridman, J. S., Minna, J. D., and Scherle, P. A. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell, 10: 39-50, 2006.
Deng, W. G., Kawashima, H., Wu, G., Jayachandran, G., Xu, K., Minna, J. D., Roth, J. A., and Ji, L. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells. Cancer Res, 67: 709-717, 2007.
Lam, D. C., Girard, L., Ramirez, R., Chau, W. S., Suen, W. S., Sheridan, S., Tin, V. P., Chung, L. P., Wong, M. P., Shay, J. W., Gazdar, A. F., Lam, W. K., and Minna, J. D. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res, 67: 4638-4647, 2007.
Whitehurst, A. W., Bodemann, B. O., Cardenas, J., Ferguson, D., Girard, L., Peyton, M., Minna, J. D., Michnoff, C., Hao, W., Roth, M. G., Xie, X. J., and White, M. A. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature, 446: 815-819, 2007.
 
 INTERESTING LINKS
 
   Department Website: Hamon Center for Therapeutic Oncology Research